Dr. Ruibin Hu is an Associate Research Fellow at Xianghu Laboratory (Zhejiang Provincial Laboratory of Agriculture), Hangzhou, China. He earned his Ph.D. in Analytical Chemistry from the Institute of Chemistry, Chinese Academy of Sciences, followed by postdoctoral research at the Southern University of Science and Technology, Shenzhen. His research focuses on the controllable fabrication of nanomaterials and the development of novel, highly sensitive biosensors for the detection of biomarkers and pathogens. Dr. Hu has published 16 SCI-indexed research articles in reputable journals such as Journal of Nanobiotechnology, Nano Research, Analytica Chimica Acta, and Computers in Biology and Medicine. He has an h-index of 6, with over 137 citations and 13 documented research outputs across various databases. His innovative NIR-II nanobead-based COVID-19 test kit achieved 100-fold higher sensitivity than conventional assays and has been successfully commercialized, generating over 10 million CNY in revenue. Dr. Hu has also been granted one national invention patent and has another under review. His contributions have been recognized with a Bronze Award at the First Postdoctoral Innovation and Entrepreneurship Competition in China. Dedicated to advancing nanotechnology-driven diagnostics, Dr. Hu continues to pioneer intelligent detection platforms for applications in personalized medicine, food safety, and environmental monitoring.